Stockreport

Ernexa Therapeutics to Present at Oxford Global’s Cell 2025

Ernexa Therapeutics Inc.  (ERNA) 
PDF CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of adva [Read more]